|
|
|
|
|
10.11.25 - 04:30
|
Research: Citi Chops ZAI LAB TP to US$58 as 3Q Rev. Below Forecast (AAStocks)
|
|
|
ZAI LAB (09688.HK)'s 3Q25 total revenue was approx. US$116 million, which is 16%/ 22% below the expectations of Citi Research/ the market each, Citi Research issued a research report saying. ZAI LAB's management significantly reduced 2025 revenue guidance target from the previous US$560-590 million to at least US$460 mil......
|
|
|
|
|
07.11.25 - 04:00
|
ZAI LAB Slumps 8% to 1-Yr+ Low; 3Q Results Miss (AAStocks)
|
|
|
ZAI LAB (09688.HK) slumped by 8.4% in early trading today (7th) to HKD17.86, the lowest since October 2024, with a trading volume of 13.064 million shares, involving HKD235 million.The company has announced its results for 3Q ended September. Under US GAAP, its total revenue rose by 14% YoY to USD116 million, while its loss narr......
|
|
|
|
|
|
|
|
|
15.10.25 - 13:33
|
Zai Lab to Announce Third Quarter 2025 Financial Results and Recent Corporate Updates on November 6, 2025 (Business Wire)
|
|
|
- Company to host conference call and webcast on November 6, 2025, at 8:00 a.m. ET (9:00 p.m. HKT)SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that it will report its third quarter 2025 financial results and provide recent corporate updates on November 6, 2025, before the opening of U.S. equity markets. The announcement will be followed by a conference call and webcast at 8:00 a.m. ET (9:00 p.m. HKT).
Conference Call and Webcast Information
The live webcast can be accessed by visiting the Company's website at http://ir.zailaboratory.com. Participants must register in advance of the conference call.
Details are as follows:
Registration link for webcast (preferred): https://edge.media-server.com/mmc/p/svanah67
Registration link for dial-in: https://register-conf.media-server.com/register/BIc22945ac95b04071a1d7c0d81eb32021
All participants must use the link provided above to complete the online registration process in advance of the conference call...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13.08.25 - 17:03
|
Zai Lab Establishes Oncology Scientific Advisory Board (Business Wire)
|
|
|
- Newly formed Advisory Board comprises world-class leaders in oncology to support advancement of Zai Lab's robust oncology products and pipelineSHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced the creation of its Oncology Scientific Advisory Board (SAB). The newly formed Oncology SAB is comprised of distinguished oncology leaders and will support the advancement of the Company's robust oncology products and pipeline, including multiple internally developed investigational therapies.
“We are honored to bring together this esteemed group of oncology leaders who will support our continued development and advancement of innovative treatment options for patients globally,” said Rafael G. Amado, M.D., President, Head of Global Research and Development, Zai Lab. “The formation of this Board is an important step for Zai; we know our clinical programs will benefit tremendously from the guidance and perspective of this highly regarded and experienced ...
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
